Αρχική World News Invasive Lobular Carcinoma Is Invisible On Mammograms, Isn’t A Lump

Invasive Lobular Carcinoma Is Invisible On Mammograms, Isn’t A Lump

Invasive lobular carcinoma (ILC) is the second most common kind of breast cancer, yet many women don’t know much about it — or how difficult it can be to find.The thing is, ILC is essentially invisible on mammograms.Elsie Spry was diagnosed with this type of breast cancer, and she was shocked and frustrated when she learned that mammograms don’t catch it.Photo: YouTube/KPRC 2 Click2HoustonSpry’s mother died from breast cancer, so she’s always been very proactive about getting her yearly mammograms. When she felt a thickening in her breast a few years ago, she was worried, but her scans came back clear.So her doctors told her she was fine.However, the thickening never dissipated. Years after she first felt it, she finally got a biopsy done on the tissue. The results of that indicated that she should get an MRI.
Photo: YouTube/KPRC 2 Click2HoustonThen Spry found out that the relief she felt every year at those clear scans had been unfounded. She had breast cancer: specifically, invasive lobular carcinoma.“I was just in shock because I thought, you know, got my i’s dotted and my t’s crossed,” Spry said.Photo: YouTube/KPRC 2 Click2Houston
Invasive ductal carcinoma (IDC), the most common type of breast cancer, is much easier to detect than ILC — depending on the density of your breasts. Typically, IDC looks something like a white patch with irregular borders, and can feel like a lump (but not always). It makes up about 8 out of 10, or 80%, of invasive breast cancers.Photo: YouTube/KPRC 2 Click2HoustonILC, on the other hand, makes up about 1 in every 10, or 10%, of invasive breast cancers. It looks different than IDC on a mammogram and typically shows up as white lines, rather than a mass. This is because ILC cancer cells tend to grow single file.“It looks like a well-marbled piece of meat, right?” Spry told Click2Houston. That’s what it looks like because it doesn’t clump. It lines up,” Spry said.
Photo: YouTube/KPRC 2 Click2HoustonDr. Eric Strom, a radiologist at MD Anderson Cancer Center, where Spry was treated, says that MRIs can be an effective tool in detecting ILC. But it could also cause a lot of unnecessary testing and biopsies in women who are actually healthy. There’s a high rate of false positives, which can cause unnecessary stress, additional tests, and even surgery. Plus, MRIs are expensive, and insurance doesn’t always cover them.The most important thing is to be aware of any changes in your breast, and if something feels different, keep fighting until you get an answer.“You need an answer. It can’t just be ‘I don’t see anything.’ That’s not an answer,” Dr. Strom said. “Especially young people who are told ‘you’re too young to get a breast cancer.’”Learn more in this video.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...

FDA Extends Approval of Pembrolizumab for Classical Hodgkin Lymphoma

On 14 October 2020, the US Food and Drug Administration (FDA) extended the approval of pembrolizumab (KEYTRUDA®, Merck Sharp & Dohme Corp.) for the...

31-Year-Old Mother Dies of Cancer After Her Chemotherapy Was Paused During the Pandemic

The COVID-19 pandemic has been a scary and difficult thing for most of the world, and it’s important to keep safety protocols in place...

For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

October 19, 2020, by NCI Staff An esophagram using barium contrast shows the esophagus. Credit: iStock Immunotherapy may become part of early treatment for some people with...

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...